期刊文献+

QUANTIFICATION OF P4HA2 mRNA OF FIBROBLASTS WITH SYBR GREEN BASED RT-PCR FOR CORRECTING CMV INACTIVATION EFFICIENCY IN DONOR BLOOD

QUANTIFICATION OF P4HA2 mRNA OF FIBROBLASTS WITH SYBR GREEN BASED RT-PCR FOR CORRECTING CMV INACTIVATION EFFICIENCY IN DONOR BLOOD
下载PDF
导出
摘要 Objective To quantify proline 4-hydroxylase, alpha polypeptide ii ( P4HA2 ) mRNA of human embryo lung fibroblast (HELF) with SYBR green based reversed transcript PCR (RT-PCR) for correcting cytomegalovirus (CMV) inactivation or clearance efficiency in donor blood. Methods A pair of specific primers of exon 12a of P4HA2 was designed, and the related PCR-reaction system and condition were optimized. Then the recombinant plasmid containing the target fragment was constructed for making standard curve with SYBR green based real-time RT-PCR. Finally, the sensitivity, reproducibility, and specificity of this method were fully estimated. Results The sensitivity of the method was 1.5E + 04 copies/mL of P4HA2 mRNA, corresponding to 10^3 fibroblasts. In addition, existence of 8. 67E + 06 leukocytes could not interfere with the accurate quantification of HELF in the large dynamic range. The intra-assay variability and inter-assay variability both varied in different concentrations, being higher in low concentrations and lower in high concentrations. But all of them were below 13. 76% in variation, which showed acceptable stability of this method. Conclusion SYBR green and specific primer based real-time RT-PCR show up a good quality for quantifying HELF P4HA2 mRNA with good specificity, stability, and high sensitivity. Approximate 10 copies of P4HA2 mRNA per cell in average can be detected by the method. Therefore, this method can be used to deduct fibroblast-associated CMV for correcting CMV inactivation efficiency in leukocytes. Objective To quantify proline 4-hydroxylase, alpha polypeptide Ⅱ (P4HA2) mRNA of human embryo lung fibroblast (HELF) with SYBR green based reversed transcript PCR (RT-PCR) for correcting cytomegalovirus (CMV) inactivation or clearance efficiency in donor blood. Methods A pair of specific primers of exon 12a of P4HA2 was designed, and the related PCR-reaction system and condition were optimized. Then the recombinant plasmid containing the target fragment was constructed for making standard curve with SYBR green based real-time RT-PCR. Finally, the sensitivity, reproducibility, and specificity of this method were fully estimated. Results The sensitivity of the method was 1.5E+04 copies/mL of P4HA2 mRNA, corresponding to 103 fibroblasts. In addition, existence of 8.67E+06 leukocytes could not interfere with the accurate quantification of HELF in the large dynamic range. The intra-assay variability and inter-assay variability both varied in different concentrations, being higher in low concentrations and lower in high concentrations. But all of them were below 13.76% in variation, which showed acceptable stability of this method. Conclusion SYBR green and specific primer based real-time RT-PCR show up a good quality for quantifying HELF P4HA2 mRNA with good specificity, stability, and high sensitivity. Approximate 10 copies of P4HA2 mRNA per cell in average can be detected by the method. Therefore, this method can be used to deduct fibroblast-associated CMV for correcting CMV inactivation efficiency in leukocytes.
出处 《Journal of Shanghai Second Medical University(Foreign Language Edition)》 2009年第2期81-86,共6页 上海第二医科大学学报(英文版)
基金 Supported by Science and Technology Commission of Shanghai, China (No.074119521)
关键词 human cytomegalovirus human embryo lung fibroblast leukocyteproline 4-hydroxylase alpha polypeptide II quantitative RT-PCR SYBR green 成纤维细胞 巨细胞病毒 荧光染料 反应效率 逆转录 聚合酶 基因 量化
  • 相关文献

参考文献10

  • 1Reeves M,,Sinclair J.Aspects of human cytomegalovirus latencyand reactivation[].Current Topics in Microbiology and Immunology.2008
  • 2Reesink HW,Engelfriet CP,Tegetmeier GE, et al.Prevention of post-transfusion cytomegalovirus: leukoreduction or screening?[].Vox Sanguinis.2002
  • 3Drew WL,Roback JD.Prevention of transfusion-transmitted cytomegalovirus: reactivation of the debate?[].Transfusion.2007
  • 4Visconti MR,Pennington J,Garner SF, et al.Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time Q-PCR[].Blood.2004
  • 5Kitajima H,Okubo Y,Honda J, et al.In vitrotransmission of HCMV between fibroblasts and peripheral blood leukocytes in the presence of IL-4[].Kurume Medical Journal.2001
  • 6Dumont LJ,Luka J,Vanden Broeke T, et al.The effect of leu- kocyte-reduction method on the amount of human cytomegalovirus in blood products: a comparison of apheresis and filtration meth- ods[].Blood.2001
  • 7A Laupacis,J Brown,B Costello.Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement[].Transfusion.2001
  • 8Nichols W G,Price T H,Gooley T,et al.Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products[].Blood.2003
  • 9Roback JD.CMVand blood transfusion[].Revs Med Virology.2002
  • 10Ziemann M,Krueger S,Maier A B, et al.High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion[].Transfusion.2007

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部